SCHEMBL17689783

SCHEMBL17689783

COc1ccc(C(C)=O)c(N)c1CI

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
LMNA P02545 4/20 0.43
KDM4E B2RXH2 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 3/20 0.41
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.37
CYP3A4 P08684 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
CTSD P07339 1/20 0.36
HPGDS O60760 1/20 0.36
PDE4A P27815 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27676520 0.79 ALDH1A1 (0.50) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL28427985 0.76 ALDH1A1 (0.47) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL7929668 0.76 ALDH1A1 (0.47) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL10983622 0.76 MAPT (0.51) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL312873 0.76 ALDH1A1 (0.47) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL312618 0.75 ALDH1A1 (0.46) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL312482 0.75 ALDH1A1 (0.46) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL4215150 0.75 ALDH1A1 (0.46) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL19705420 0.73 LMNA (0.47) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL27941215 0.72 ALDH1A1 (0.51) ALDH1A1LMNAKDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2461811-B1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX PHARMACEUTICALS LLC (US) 2016-04-20 EP disclosed